Phase I Study of Olaparib and Temozolomide for Ewings Sarcoma or Rhabdoomyosarcoma
Clinical trial NCT01858168 · COMPLETED
Trial details
- NCT number
- NCT01858168
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2024-11-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.